These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19697359)

  • 1. Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer.
    Jehan Z; Bavi P; Sultana M; Abubaker J; Bu R; Hussain A; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Nov; 219(3):337-46. PubMed ID: 19697359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIK3CA mutation and amplification in human lung cancer.
    Okudela K; Suzuki M; Kageyama S; Bunai T; Nagura K; Igarashi H; Takamochi K; Suzuki K; Yamada T; Niwa H; Ohashi R; Ogawa H; Mori H; Kitamura H; Kaneko T; Tsuneyoshi T; Sugimura H
    Pathol Int; 2007 Oct; 57(10):664-71. PubMed ID: 17803655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma.
    Woenckhaus J; Steger K; Werner E; Fenic I; Gamerdinger U; Dreyer T; Stahl U
    J Pathol; 2002 Nov; 198(3):335-42. PubMed ID: 12375266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
    Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
    Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.
    Estilo CL; O-Charoenrat P; Ngai I; Patel SG; Reddy PG; Dao S; Shaha AR; Kraus DH; Boyle JO; Wong RJ; Pfister DG; Huryn JM; Zlotolow IM; Shah JP; Singh B
    Clin Cancer Res; 2003 Jun; 9(6):2300-6. PubMed ID: 12796399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients.
    Morrison C; Zanagnolo V; Ramirez N; Cohn DE; Kelbick N; Copeland L; Maxwell GL; Fowler JM
    J Clin Oncol; 2006 May; 24(15):2376-85. PubMed ID: 16710036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression.
    Carvalho B; Postma C; Mongera S; Hopmans E; Diskin S; van de Wiel MA; van Criekinge W; Thas O; Matthäi A; Cuesta MA; Terhaar Sive Droste JS; Craanen M; Schröck E; Ylstra B; Meijer GA
    Gut; 2009 Jan; 58(1):79-89. PubMed ID: 18829976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis.
    Aust DE; Muders M; Köhler A; Schmidt M; Diebold J; Müller C; Löhrs U; Waldman FM; Baretton GB
    Scand J Gastroenterol; 2004 Aug; 39(8):766-72. PubMed ID: 15513363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population.
    Abubaker J; Bavi P; Al-Harbi S; Ibrahim M; Siraj AK; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    Oncogene; 2008 Jun; 27(25):3539-45. PubMed ID: 18193083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma.
    Wada S; Noguchi T; Takeno S; Kawahara K
    Ann Surg Oncol; 2006 Jul; 13(7):961-6. PubMed ID: 16788758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers.
    Krajewska M; Kim H; Kim C; Kang H; Welsh K; Matsuzawa S; Tsukamoto M; Thomas RG; Assa-Munt N; Piao Z; Suzuki K; Perucho M; Krajewski S; Reed JC
    Clin Cancer Res; 2005 Aug; 11(15):5451-61. PubMed ID: 16061861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
    Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
    Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The candidate oncogene ZNF217 is frequently amplified in colon cancer.
    Rooney PH; Boonsong A; McFadyen MC; McLeod HL; Cassidy J; Curran S; Murray GI
    J Pathol; 2004 Nov; 204(3):282-8. PubMed ID: 15476264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
    Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.